معرفی
Douwe Postmus is a researcher at the Faculty of Medical Sciences at University of Groningen, affiliated with the Life Course Epidemiology (LCE) and Value, Affordability and Sustainability (VALUE) research groups. His work spans epidemiology, pharmacology, and patient-centered healthcare decision-making, with a focus on aging populations and oncology.
- Expertise in epidemiological modeling, clinical pharmacology, and patient preference analysis
- Active in UN Sustainable Development Goals related to health equity and sustainable healthcare systems
Recent research includes lung cancer treatment complications, multimorbidity in aging, diabetes decision aids, and regulatory frameworks for oncology drugs. His methodological work involves multistate Markov models, competing risks analysis, and user-centered e-learning design.
As a speaker, Postmus has presented on conditional cancer drug approval, real-world data applications, and benefit-risk analysis frameworks at international academic conferences from 2023-2024.
- Contributed to datasets on stated preference studies in multiple myeloma patients (2017)
- Active in medical education innovation through e-learning platforms
